Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019163 (
hepatitis B
)
38,309
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Urocanic acid
(
UCA
) is a major UV-absorbing chromophore in the epidermis and has been suggested to act as one of the initiators of UV-induced immunosuppression. cis-
UCA
, the isomer from
UCA
that is formed upon UV exposure, has been shown to impair some cellular immune responses. cis-
UCA
levels were determined in a study in which the influence of ultraviolet B (UVB) exposure on immune responses after
hepatitis B
vaccination in human volunteers was established. A significant increase in cis-
UCA
levels was found in the skin of UVB-exposed volunteers compared with controls. cis-
UCA
levels, calculated as the percentage of the total
UCA
amount, in UVB-exposed volunteers correlated significantly with the cumulative UVB dose received in 5 consecutive days, i.e. the higher the UVB dose (J/m2), the higher the cis-
UCA
levels (until a cis-
UCA
plateau was reached in the so-called photostationary state). Correlations between skin cis-
UCA
levels and immune responses were determined, and they revealed no statistically significant correlations among lymphocyte proliferation responses after either mitogenic stimulation or stimulation with recall antigens. No correlation was found between cis-
UCA
levels and
hepatitis B
-specific antibody titers. However, we found a statistically significant negative correlation between cis-
UCA
levels and
hepatitis B
-specific lymphocyte proliferation responses when volunteers were irradiated with UVB before
hepatitis B
vaccination. In other words, volunteers with high cis-
UCA
levels caused by UVB exposure showed lower cellular immune responses against
hepatitis B
antigen after
hepatitis B
vaccination.
...
PMID:Epidermal cis-urocanic acid levels correlate with lower specific cellular immune responses after hepatitis B vaccination of ultraviolet B-exposed humans. 1268 54